Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Maria Cecilia BahitRalph L SaccoJ Donald EastonJuliane MeyerhoffLisa CroninEva KleineClaudia GrauerMartina BrueckmannHans-Christoph DienerRenato Deláscio LopesMichael BraininPhillippe LyrerRolf WachterTomas SeguraChristopher B Grangernull nullPublished in: Circulation (2021)
Besides age, the most important variable, several other factors, including hypertension, higher body mass index, and lack of diabetes, are independent predictors of AF after embolic stroke of undetermined source. When baseline NT-proBNP was available, only older age and elevation of this biomarker were predictive of subsequent AF. Understanding who is at higher risk of developing AF will assist in identifying patients who may benefit from more intense, long-term cardiac monitoring. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02239120.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- blood pressure
- heart failure
- type diabetes
- percutaneous coronary intervention
- cardiovascular disease
- clinical trial
- study protocol
- physical activity
- community dwelling
- phase iii
- glycemic control
- phase ii
- middle aged
- venous thromboembolism
- pet ct
- blood brain barrier
- insulin resistance
- weight loss